Key facts
- This page summarizes Dennis Erani's Form 4 filing for Organogenesis Holdings Inc. (ORGO).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Dec 2021, 20:00.
Dennis Erani - 15 Dec 2021 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ORGO
- Reported as of
- 15 Dec 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Dec 2021, 20:00:32 UTC
- Prior SEC filing
- 28 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stacie S. Aarestad, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Dennis Erani filed Form 4 for Organogenesis Holdings Inc. (ORGO) on 17 Dec 2021.
Change
- Previous filing in this sequence was filed on 28 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ORGO
transaction
Class A Common Stock
Gift
- Transaction value
- $0
- Shares
- -5,417,900
- Change %
- -8.4%
- Price
- $0.000000
- Shares after
- 59,448,027
- Date
- 15 Dec 2021
- Ownership
- By the Dennis Erani 2014 GRAT
- Footnotes
- F1, F2
ORGO
transaction
Class A Common Stock
Gift
- Transaction value
- $0
- Shares
- +5,417,900
- Change %
- +10%
- Price
- $0.000000
- Shares after
- 59,448,027
- Date
- 15 Dec 2021
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reported securities, which were indirectly held by Dennis Erani, a member of the Group (as defined below), were transferred by the Dennis Erani 2014 GRAT to the Dennis Erani 2012 Issue Trust dated 12/20/12, which is a member of the Group, for no consideration. None of the other members of the Group has a pecuniary interest in the transferred securities.
Footnote F2
Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.
SEC remarks
Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom and certain of their respective affiliates, including Organo PFG LLC, Organo Investors LLC, Dennis Erani 2012 Issue Trust, Alan Ades as Trustee of the Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, GN 2016 Family Trust u/a/d August 12, 2016 and GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, referred to collectively as the "Group", are parties to a Controlling Stockholders' Agreement dated December 10, 2018 with Organogenesis Holdings Inc. (the "Stockholders' Agreement"). The Stockholders' Agreement, among other things, provides for nomination rights of the Group with respect to four directors of the Issuer. As a result of the Stockholders' Agreement, the reporting persons may be deemed to be members of a group holding over 10% of the outstanding shares of common stock of the issuer for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. This is Form 4 No. 2 of 2 filed for the Group.